Institute of Immunology, Laboratoire National de Santé/Centre de Recherche Public de la Santé, 20A rue Auguste Lumière, L-1950 Luxembourg.
Psychoneuroendocrinology. 2010 May;35(4):544-56. doi: 10.1016/j.psyneuen.2009.09.001. Epub 2009 Sep 25.
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRalpha, GRbeta and GR-P transcripts were homogeneous throughout the limbic system, with GRalpha being the most abundant (83%), followed by GR-P (5-6%) while GRbeta was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRalpha was decreased in the amygdala and cingulate gyrus (p<0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.
下丘脑-垂体-肾上腺 (HPA) 轴的过度活跃是重度抑郁症 (MDD) 中最一致的发现之一。HPA 反馈受损可能是由于前脑中糖皮质激素受体 (GR) 或盐皮质激素受体 (MR) 水平降低所致。GR 水平受多个未翻译的替代第一外显子的转录控制,每个外显子都有自己的启动子,为 GR 水平的组织特异性精细调节提供了机制。最近,这些 GR 启动子的表观遗传甲基化被证明可以调节海马体中的 GR 水平。在这里,我们在死后脑组织中研究了 HPA 轴在 MDD 中的过度活跃是否可能是由于 GR 转录变体的表观遗传调节所致。GRalpha、GRbeta 和 GR-P 转录本在边缘系统中均匀分布,GRalpha 最为丰富 (83%),其次是 GR-P (5-6%),而 GRbeta 几乎无法检测到 (0.02%)。在替代的第一外显子中,1B 和 1C 最为活跃,而 1E 和 1J 表达水平最低,1F 表达水平中等,约为 1%。在 MDD 中,总 GR 水平没有改变,尽管杏仁核和扣带回中的 GRalpha 减少 (p<0.05);包含外显子 1B、1C 和 1F 的转录本降低,而在一些区域 1D 和 1J 增加。MDD 患者海马体中的转录因子 NGFI-A 下调,同时外显子 1F 的表达减少。替代启动子的亚硫酸氢盐测序显示,MDD 和对照组大脑中的甲基化水平均较低。1F 启动子均匀未甲基化,表明 1F 转录本水平降低与启动子甲基化无关,而是与观察到的 NGFI-A 缺乏有关。以前的研究表明,1F 启动子中的高甲基化水平与儿童期虐待有关。鉴于我们的供体没有受到虐待,我们的研究结果表明,MDD 的发病机制与虐待受害者相似但又不同,这解释了这两种情况的临床相似性,以及易患抑郁症可能是由早期创伤引起的,也可能是独立于这种情况发展的。然而,在更大的队列中进行专门的研究应进一步证实这一点。